{"disease":{"id":"lymphatic-malformation","name":"lymphatic malformation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06943703","title":"Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma","phase":"","overall_status":"COMPLETED","enrollment_count":809,"lead_sponsor_name":"National Children's Hospital, Vietnam","has_results":false},{"nct_id":"NCT03427619","title":"OK432 (Picibanil) in the Treatment of Lymphatic Malformations","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":275,"lead_sponsor_name":"Richard JH Smith","has_results":true},{"nct_id":"NCT05948943","title":"Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":232,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT06437158","title":"Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT06673290","title":"Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT06275022","title":"A Prospective Study on the Treatment of cLM Based on ICG Imaging","phase":"NA","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"Nanjing Children's Hospital","has_results":false},{"nct_id":"NCT04921722","title":"Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":75,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT06892964","title":"Institution of an Italian Registry and Biobank for Biological Sample Collection","phase":"NA","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03972592","title":"Topical Sirolimus in Cutaneous Lymphatic Malformations","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"University Hospital, Tours","has_results":false},{"nct_id":"NCT06755905","title":"Indocyanine Green Lymphography in Management of Lingual Lymphatic Malformation","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Nanjing Children's Hospital","has_results":false},{"nct_id":"NCT07189832","title":"Bleomycin Intralesional Injections of Cystic Hygromas","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Delta University for Science and Technology","has_results":false},{"nct_id":"NCT07378657","title":"Systematic Approach for Children With Orbital Malformation With Sirolimus Use","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT05563831","title":"National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)","phase":"","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT02335242","title":"Sildenafil for the Treatment of Lymphatic Malformations","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Stanford University","has_results":true},{"nct_id":"NCT06994260","title":"Diagnostic Imaging of Vascular Malformations Using MSOT and ULM","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"University Hospital Erlangen","has_results":false},{"nct_id":"NCT04409145","title":"First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"Venthera, Inc., a BridgeBio company","has_results":false},{"nct_id":"NCT04128722","title":"TOPical Sirolimus in linGUal Microcystic Lymphatic Malformation -TOPGUN","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"University Hospital, Tours","has_results":false},{"nct_id":"NCT05050149","title":"Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Palvella Therapeutics, Inc.","has_results":true},{"nct_id":"NCT06160739","title":"Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations","phase":"","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT04836884","title":"Vascular Anomaly Pathology and Genomics Biopsy Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"Mayo Clinic","has_results":false}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}